Becker Marcus
Known title: SVP CPOCIK: 0002092960
Associated companies
Transaction History
| CSTM | ▼ Sell | Open Market | 10,391 | $363K | 5/28/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 10,000 | $251K | 3/16/2026 | View on chart |
| CSTM | ▲ Buy | Grant | 3,938 | $0 | 3/12/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 1,113 | $29K | 3/10/2026 | View on chart |
| CSTM | ▲ Buy | Open Market | 14,592 | $0 | 3/9/2026 | View on chart |
| CSTM | ▼ Sell | Open Market | 15,570 | $398K | 2/20/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays initiates coverage on Constellium with Equal-Weight rating
Barclays has started covering Constellium with an Equal-Weight rating and a $28 price target. This new analyst view comes as the company prepares to report its third-quarter results on October 28, 2026. While some analysts suggest the stock could see further gains, the new target is below the current average analyst estimate of $33.67.
Barclays initiates coverage on Constellium with Equal-Weight rating. Barclays has started covering Constellium with an Equal-Weight rating and a $28 price target. This new analyst view comes as the company prepares to report its third-quarter results on October 28, 2026. While some analysts suggest the stock could see further gains, the new target is below the current average analyst estimate of $33.67.